• FirefoxUpgrade to the new Firefox »
  •  Dow Up 2.43% Nasdaq Up 2.24%

    Impax Laboratories Inc. (IPXL)

    -NasdaqGS
    30.79 0.86(2.86%) Dec 18, 4:00PM EST
    Add to Portfolio
    Prev Close:29.93
    Open:30.17
    Bid:N/A
    Ask:44.83 x 100
    1y Target Est:32.08
    Beta:1.82
    Earnings Date:Feb 18 - Feb 23 (Est.)
    Day's Range:29.89 - 30.95
    52wk Range:21.34 - 33.05
    Volume:602,951
    Avg Vol (3m):623,045
    Market Cap:2.10B
    P/E (ttm):45.81
    EPS (ttm):0.67
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    IPXLUp 2.86%2.10B
    MYL21.27B
    TEVA48.42B

    Key Statistics

    Forward P/E (1 yr):18.66
    P/S (ttm):3.62
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :1.29
    Quarterly EPS Est (Dec-14) :0.11
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):2.43

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Impax Laboratories, Inc., a specialty pharmaceutical company, develops, manufactures, and markets bioequivalent pharmaceutical products; and develops and markets branded products. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback